RxDoctor Payments Data

Rachel Smith

Physician Assistant · Longview, TXNPI 1851323919

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 436 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 24.1% of the total. 2025 is the largest year on record at $2,764, 2.8 times the $976 reported in 2021. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,427in general payments, 2019–2025

Across 436 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$758
  • Lilly USA, LLC$748
  • Regeneron Healthcare Solutions, Inc.$727
  • Novartis$538
  • Johnson & Johnson$477
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$8,00695%
  • Education$4215%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,427 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Medicare billing

Part B allowed, 2024
$315,200
Medicare patients
848
Services billed
15,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab12$193,238
Cosentyx Unoready PenSecukinumab20$157,486
Taltz AutoinjectorIxekizumab14$116,019
Minocycline Hcl100$3,755
Betamethasone Dipropionate66$2,561
Clobetasol Propionate77$2,505
Mometasone Furoate106$2,333
Metronidazole30$1,990
MethotrexateMethotrexate Sodium101$1,913
Ketoconazole110$1,683
Triamcinolone Acetonide66$983
Doxycycline Hyclate56$812
Terbinafine Hcl21$408
Hydrocortisone45$376
ValacyclovirValacyclovir Hcl16$319

Paid to pharmacies, not to this prescriber.

Other physician assistant in Longview

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →